Beyond immune modulation, we also propose cancer proliferation in HCC to be regulated via TPC2/MAPK axis, as the Ras/Raf/MAPK pathway is a well-established driver of tumour growth and survival and is hyperactivated in HCC (78, 79). Here, TPCN2 is linked to cancer.